Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420316
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2007-01-10
Brief Title:
Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bios HRV Vaccine
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2007-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-10
First Submit QC Date:
January 10 2007
Study First Post Date:
2007-01-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-02-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-23
Last Update Post Date:
2018-08-28
Last Update Post Date Type:
ACTUAL